Medicover Cancer Institute performs minimal access surgery to treat lung cancer

Traditionally, treating such tumors involved extensive surgery, which often required the removal of a lung lobe through thoracic incisions. This approach resulted in prolonged hospital stays and significant post-operative weakness. However, Dr Pavan Kumar Jonmada recognized the potential for improved patient outcomes and proposed an innovative alternative: minimal access surgery.

This transformative approach not only reduces physical trauma but also accelerates the recovery process, allowing patients to resume their normal lives with minimal interruption. Dr Pavan Kumar Jonmada's dedication to patient welfare and medical advancement highlights the Medicover Cancer Institute's commitment to pushing the boundaries of cancer treatment.

Dr Pavan Kumar Jonmada emphasized, "Minimal access surgery represents a significant advancement in lung cancer treatment. By utilizing advanced techniques and technology, we provide patients with a faster and less invasive path to recovery. With just two stitches and a brief hospital stay of two days, we achieve remarkable outcomes while prioritizing patient comfort and well-being. This approach reflects our dedication to medical innovation and compassionate patient care."